Management of Recurrent Gastrointestinal Stromal Tumors

被引：15

作者：

Winer, Joshua H. ^{[1
,2
]}

Raut, Chandrajit P. ^{[1
,2
,3
]}

机构：

[1] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 08期

关键词：

recurrent gastrointestinal stromal tumor; imatinib mesylate; sunitinib malate; surgery; neoadjuvant therapy; blood level testing; PHASE-II TRIAL; IMATINIB MESYLATE; SURGICAL RESECTION; RESIDUAL DISEASE; TYROSINE-KINASE; DOSE IMATINIB; GIST; THERAPY; SURGERY; KIT;

D O I：

10.1002/jso.21890

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recurrence after resection of primary gastrointestinal stromal tumor (GIST) is an unfortunately all-too-common phenomenon. The principal treatment for recurrent GIST is the first-line tyrosine kinase inhibitor (TKI) imatinib mesylate. Those who progress on, or are intolerant of imatinib, are treated with second-line TKI sunitinib malate. Cytoreductive surgery may be considered as an "adjuvant" therapy for patients with disease stabilized on imatinib, and, on an individual basis, sunitinib. J. Surg. Oncol. 2011;104:915-920. (C) 2011 Wiley Periodicals, Inc.

引用

页码：915 / 920

页数：6

共 50 条

[1] Gastrointestinal Stromal Tumors Presenting as Recurrent Gastrointestinal Bleeding
Afaq, Safia
Khan, Taimur
Mishal, Nadia
Miao, Chuan L.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2405 - S2406
[2] Management of gastrointestinal stromal tumors
Hueman, Matthew T.
Schulick, Richard D.
SURGICAL CLINICS OF NORTH AMERICA, 2008, 88 (03) : 599 - +
[3] Management of gastrointestinal stromal tumors
Rajendra, Rajeev
Pollack, Seth M.
Jones, Robin L.
FUTURE ONCOLOGY, 2013, 9 (02) : 193 - 206
[4] Management of Gastrointestinal Stromal Tumors
Keung, Emily Z.
Raut, Chandrajit P.
SURGICAL CLINICS OF NORTH AMERICA, 2017, 97 (02) : 437 - +
[5] Management of Gastrointestinal Stromal Tumors
von Mehren, Margaret
SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (05) : 1059 - +
[6] Recurrent epimutation of SDHC in gastrointestinal stromal tumors
Killian, J. Keith
Miettinen, Markku
Walker, Robert L.
Wang, Yonghong
Zhu, Yuelin Jack
Waterfall, Joshua J.
Noyes, Natalia
Retnakumar, Parvathy
Yang, Zhiming
Smith, William I., Jr.
Killian, M. Scott
Lau, C. Christopher
Pineda, Marbin
Walling, Jennifer
Stevenson, Holly
Smith, Carly
Wang, Zengfeng
Lasota, Jerzy
Kim, Su Young
Boikos, Sosipatros A.
Helman, Lee J.
Meltzer, Paul S.
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (268) : 268ra177
[7] Surgical Management of Gastrointestinal Stromal Tumors
Frankel, Timothy L.
Wong, Sandra L.
CURRENT PROBLEMS IN CANCER, 2011, 35 (05) : 271 - 282
[8] Gastrointestinal Stromal Tumors: Current Management
Pisters, Peter W. T.
Patel, Shreyaskumar R.
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (05) : 530 - 538
[9] Controversies in the management of gastrointestinal stromal tumors
Yip, Desmond
Zalcberg, John
Ackland, Stephen
Barbour, Andrew P.
Desai, Jayesh
Fox, Stephen
Kotasek, Dusan
McArthur, Grant
Smithers, B. Mark
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 216 - 227
[10] Laparoscopic management of gastrointestinal stromal tumors
Nguyen, S. Q.
Divino, C. M.
Wang, J. -L.
Dikman, S. H.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (05): : 713 - 716

← 1 2 3 4 5 →